News
DermaPlus, Inc. offers Tropoelastin to organizations engaged in organ and tissue regeneration; product sales supports research
New York – November 14, 2006 – DermaPlus, Inc. is offering research quantities of its laboratory synthesized human Tropoelastin to qualified organizations engaged in organ and tissue regeneration research. The Company’s version of Tropoelastin, trademarked Elastatropin, can be used as a cost-effective and reliable scaffold material and connective matrix to bind and reinforce cells when growing cells into organ-like masses. The DermaPlus business model in place is using revenue from their successful DermaLastyl skin cream products to make plentiful quantities of Tropoelastin/Elastatropin available for organ and tissue regeneration research.
Dr. Burt Ensley, DermaPlus CEO notes, “Tropoelastin/Elastatropin is the perfect material for these organ and tissue regeneration projects, and existing and future customers can contribute and support the advance of medical science when they purchase a jar of our very successful DermaLastyl skin cream. Other sophisticated synthesized human matrix proteins that could be similarly used to maintain the integrity and shape of an organ can cost up to $1 million per gram. Our Company, with the help of its customers, is offering low-cost Elastatropin on a case-by-case basis to qualified organizations to expedite organ and tissue regeneration projects.”
Elastatropin is currently used to reduce wrinkles in the successful DermaLastyl line of Face and Eye serum products. Elastatropin is a complex chain of 600 amino acids in a patented molecular delivery system to restore elastic properties to skin. It is successfully reducing wrinkles by penetrating the deepest parts of the topmost layer of skin, entering into the outer skin layers, cross-linking with existing elastin and other skin matrix proteins and expanding the flexible backbone of the skin.
For further information, qualified organ and tissue regeneration research organizations should call 800-335-8312.
About Matrix Design/DermaPlus
Matrix Design, Inc./DermaPlus, Inc. is a biotechnology company that designs and manufactures sophisticated, high performance biomaterials such as Tropoelastin-based Elastatropin for use in the cosmeceutical and personal care products. Based on human genetic sequences, these biomaterials can be customized to reflect the genetic makeup of human tissues, population groups or even single individuals. DermaLastyl-B, DermaLastyl-E, DermaLastyl-Bx Pro/Face, and DermaLastyl-Ex are the first genetically engineered products on the market that help restore elastin and elastic properties to the skin and around the eyes. Used properly, DermaLastyl could postpone the need for Botox or cosmetic surgery and possibly extends the life of previous cosmetic procedures. Keracyte-b is designed to stimulate and re-vitalize hair follicles so as to allow existing hair shafts to grow thicker and stronger.
Available only at DermaLastyl.com, DermaLastylPro.com, or Keracyte.com and 800-335-8312
Contact:
Jerry Jennings
Emerson Gerard Associates
561-881-7318
mediareply@egaplus.com